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Summary
Spleen cells from CBA/J mice immunized with mouse thyroglobulin (MTg) and the adjuvant
lipopolysaccharide induce experimental autoimmune thyroiditis (EAT) after transfer to recipient
mice if they are first activated in vitro with MTg. EAT induced by cells cultured with MTg
is generally moderate in severity and is characterized by a thyroid infiltration consisting primarily
of mononuclear cells. Addition of the anti-interleukin 2 receptor (IL2R) monoclonal antibodies
(mAbs) M7/20, 3C7, or 7D4 to spleen cell cultures with MTg resulted in a cell population
capable of inducing a more severe type of EAT characterized by extensive follicular destruction,
granuloma formation, and the presence of multinucleated giant cells. Recipients ofcellscultured
with MTg and anti-IL-2R mAb also had higher anti-MTg autoantibody responses than recipients
ofcells cultured with MTg alone. Activation of cells capable oftransferring severe granulomatous
EAT and increased anti-MTg autoantibody responses required both MTg and M7/20 in culture
and required addition of M7/20 within the first 8 h of the 72-h culture period. CD4+ T cells
were required for the expression of both the severe granulomatous EAT lesions and the mononuclear
cell infiltrates typically observed in murine EAT. The increased anti-MTg autoantibody responses
in recipients of cells cultured with MTg and anti-IL-2R mAbs were not restricted to a particular
immunoglobulin G (IgG) subclass and included antibody ofthe IgG1, IgG2A, and IgG2B subclasses.
These results suggest that a subset of CD4+ T cells capable of inducing severe granulomatous
EAT and increased anti-MTg autoantibody responses is preferentially activated when cells are
cultured in the presence of anti-IL2R mAb. Anti-IL2R mAb may either prevent activation of
cells that induce classical lymphocytic EAT or prevent activation of cells that normally function
to downregulate EAT effector T cell activity.
R
ecent studies have established that mAbs directed against
surface molecules on T cells or other cells involved in
immune responses to autoantigens can prevent the develop-
ment of many experimentally induced and spontaneous au-
toimmune diseases (reviewed in references 1-3). Antibodies
such as anti-CD4 directed against the CD4 molecule expressed
on CD4+ T cells and those directed against class II MHC
molecules (Ia) expressed on APC have also been shown to
be effective in preventing disease when mAb treatment is begun
after effector cells have been sensitized or after clinical signs
of the disease are evident (4-10). While these observations
suggest that anti-CD4 or anti-la mAbs might be useful for
therapy ofhuman autoimmunediseases, these mAbs also elim-
inate many cells other than those involved in mediating the
autoimmune response. For this reason, it would be desirable
to use mAbs that target a more restrictedpopulation of cells
to suppress autoimmune disease. Since recently activated T
and B cells express IL2Rs, which are not present on resting
cells (11), several studies have recently assessed the ability of
anti-IL2R mAbs to prevent or arrest autoimmune diseases
in animals. Anti-IL2R mAbs have been shown to suppress
the development oflupus nephritis in NZB/NZW mice (12),
insulitis in NOD mice (12) and BB rats (13), and thymectomy-
induced thyroiditis in Buffalo rats (14). In addition, experimen-
tally induced allergic encephalomyelitis (EAE)' and adjuvant
arthritis in rats were suppressed by administration of anti-
IL-2RmAb to recipients ofsensitizedcells (15, 16) or by adding
' Abbreviations used in this paper: EAE, experimentally induced allergic
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of T cells (17) .
Experimental autoimmune thyroiditis (EAT) is a chronic
inflammatory autoimmune disease that canbe induced in ge-
netically susceptible mice by injection of mouse thyroglobulin
(MTg) and adjuvant (18, 19). Splenic lymphocytes from mice
primed with MTg and adjuvant can transfer EAT to normal
or irradiated syngeneic recipients afterinvitro activation with
MTg (20). CD4+ T cells are required for the induction of
EAT in this model (4, 10), and CD4+ T cell lines or clones
can induce EAT after transfer to irradiatedmice (21, 22), sug-
gesting that CD4+ T cells are the major effector cells for
EAT in mice. Our laboratory has recently used this cell transfer
system, together with mAbs directed against various cell sur-
face molecules, to elucidate the cellular mechanisms involved
in the development ofEAT in mice. These studies established
that CD4+ T cells and Ia+ APC are required for both the
induction and expression of EAT (4, 5). Moreover, addition
of either anti-CD4 or anti-I-Ak mAb to cultures during in
vitro activation of EAT effector cells blocked MTg-specific
proliferative responses, and cells cultured in the presence of
these mAbs could not transfer EAT to recipient mice (4, 5, 23).
The present studies were initially undertaken in order to
determine if activated EAT effector T cells expressed IL2R.
To address this question, we asked whether addition of anti-
IL2R mAb during the in vitro activation of EAT effector
cellswould block the in vitro activation of EAT effector cells
and prevent the ability of cells to transfer EAT It will be
shown that although addition of anti-IL2R mAb to cultures
containing MTg-sensitized cells and MTg effectively blocked
the antigen- and mitogen-induced proliferation of MTg-
sensitized T cells, cells cultured with anti-IL2R mAb unex-
pectedly transferred more severe EAT to mice than did cells
cultured with MTg alone. Moreover, recipients of cells cul-
tured with anti-IL-2R mAb produced markedly increased anti-
MTg autoantibody responses, and the histopathology of the
EAT lesions differed substantially from the typical lympho-
cyticthyroiditis observed after active immunization with MTg
and adjuvant (18, 19) or after transfer of in vitro activated
CD4+ T cells to normal or irradiated mice (4, 5, 20, 22).
Thyroids of mice receiving cells cultured in the presence of
anti-IL2R mAb were almost completely destroyed, and
the lesions were primarily granulomatous in nature. Since
CD4+ T cells are also required for development of this
granulomatous form of EAT, these results raisethe possibility
that a subset of CD4+ T cells resistant to the inhibitory
effects of anti-IL-2R mAbs has the capacity to induce severe
granulomatous EAT in mice. These results may have impor-
tant significance for furthering our understanding of the regu-





CBA/J mice were obtained through C. Reeder at the
National Institutes of Health (Bethesda, MD) or were from our
breeding colonies at the University of Missouri (Columbia, MO).
Male or female mice, 6-8 wk old, were used for all experiments.
mAbs.
￿
Culture supernatants containing the mAb MI/87.27.7
(anti-Forssman; rat IgM) (24) were produced from cells obtained
from the American Type Culture Collection, Rockville, MD). Cul-
ture supernatants containingthe mAb M7/20 (anti-IIr2R; rat IgM)
(25) were produced from cells supplied by Dr. G. Gaulton, Univer-
sity of Pennsylvania (Philadelphia, PA), and culture supernatants
containing the anti-IL2R mAb 3C7 (rat IgG) (26) and anti-IL2R
mAb 7D4 (rat IgM) (26) were produced from cells supplied by
Dr. M. Misfeldt, University ofMissouri. The 7D4 and M7/20 cul-
ture supernatants inhibited proliferation of the HT-2 cell line in-
duced by rIL2 (Genzyme, Boston, MA) but had no effect on HT-2
proliferation induced by rIIT4(kindly supplied by Dr. S. Gillis, Im-
munex Corp., Seattle, WA). Ascites containing the anti-CD4 mAb
GK1.5 were prepared as previouslydescribed (4) . Mice received 0.3
ml GK1.5 ascites intraperitoneally 4 or 11 d after transfer of MTg-
activated spleen cells (4).
Antigen and Immunization of Donor Mice.
￿
MTg was prepared
as previouslydescribed (20). Mice were injected twice intravenously
at 10-d intervals with 150 Kg MTg and 15 ug LPS (20).
Cell Transfer System.
￿
7 d after the second injection ofMTg and
LPS, spleen cells from donor mice were prepared at 10'/ml in
RPMI 1640 containing 25 mM Hepes buffer (MA Bioproducts,
Walkersville, MD), 5% FCS (Lot 3061; Hazelton Laboratories,
Denver, PA, or Lot 1115774; HyClone Laboratories, Logan, UT),
glutamine, MEM vitamin solution, nonessential amino acids, so-
dium pyruvate, penicillin-streptomycin (all from Hazelton Labora-
tories), and 5 x 10-5 M 2-ME. Cells were cultured in 60-mm
petri dishes (4 ml/plate) with 20-25 Pg/ml MTg at 37°C for 68-72
h (20). Culture supernatants containing M7/20 or other mAbs
were added as indicated for each experiment to a final concentra-
tion of 5%. Unless indicated otherwise, mAbs were always added
at initiation of culture. Cells were harvested, washed twice in
balanced salt solution, and 2.5 x 10' cells were transferred intra-
venously into 600 rad irradiated syngeneic recipients (20, 27). In
all experiments, the number of cells transferred to recipient mice
was based on the count of the total recovered cells. No correction
was made for differences in viability, which, as noted below, was
generally lower for cells cultured with mAb M7/20. In some ex-
periments, recipient mice were given 0.25 ml anti-CD4 (GK1.5)
ascites 4 or 11 d after cell transfer (4). Recipient thyroids were re-
moved 8, 11, or 19 d after cell transfer. EAT induced by in vitro
activated spleen cells is first detectable 7-8 d after cells transfer;
the severity of EAT becomes maximal 17-21 d after cell transfer
in both irradiated (27) and unirradiated recipients (20).
Evaluation ofEAT.
￿
Histologicevaluation of thyroid lesions was
on a scale of 1+ to 4+ as previously described (20). Briefly, 1+
thyroiditis is defined as an infiltrate of at least 125 cells in one or
several foci, 2+ is 10-20 foci of cellular infiltration involving up
to one-fourth of the gland, 3+ indicate one-fourth to one-half of
the gland is infiltrated, and 4+ indicates that greater than one-half
of the gland is infiltrated. The cellular infiltrate in typical EAT le-
sions consists primarily of small lymphocytes, macrophages, and
a few PMN. In the studies reported here, the lesions in many of
the recipients ofcells cultured with anti-11,2R. mAb also contained
large numbers of histiocytes, including multinucleated giant cells,
and theselesions were characterized by granulomatous changes (see
Results). Thyroids with these latter features were almost totally
infiltrated by cells and were also grossly enlarged. Because these
thyroids had a more severe form of EAT lesion than found in typ-
ical 4+ lymphocytic thyroiditis, the animals with these severe
granulomatous lesions are scored as 5+ in the tables.
ELISA.
￿
Serum levels of MTg-specific IgG autoantibodies were
assessed by ELISA as described in detail previously(27). For some
900
￿
Anti-interleukin 2 Receptor Antibody Effect on Autoimmune Thyroiditisexperiments, the contribution ofvariousIgG subclasses to the total
IgG autoantibody response was assessed using developing antisera
specific for mouse IgG1, IgG2A, IgG2B, and IgG3 (Southern Bio-
technology, Inc., Birmingham, AL) (5) .
Proliferation Assay . Spleen cells were plated in 96-well flat-
bottomed plates (25860 ; Coming Glass Works, Coming; NY) at
5 x 105 cells/well in a final volume of 0.2 ml . MTg (25 or 50
4g/ml), OVA (50 ug/ml), ConA (5 hg/ml), PHA (5 p.g/ml), or
LPS (500 Pg/ml) was added in a volume of0.1 ml . Plates were
incubated for 24, 48, or 72 h, 0.5 P.Ci ['H]TdR was added, and
cells were harvested 16-20 h later (28) . Results are expressed as
themeanAcpm of triplicate cultures (cpmwith antigen or mitogen
cpm with media alone) . Details of this assay were described previ-
ously (28) .
Fluorescence Analysis. Spleen cells from MTg/LPS-sensitized
donors were cultured in 60-mm plates in media or with culture
supernatant containing the mAb M7/20 (5% final concentration)
in the presence or absence of 25 ug/ml MTg . After 24, 48, or
72 h, viable cells were isolated on Ficoll-hypaque (Pharmacia Fine
Chemicals, Piscataway, NJ) . Cells were stained with M7/20,
anti-Forsmann IgM, anti-CD4 (GK1 .5), or anti-CDS (53-6.72)
(29) followed by a secondary FITC-labeled anti-rat IgG (Southern
Biotechnology, Birmingham, AL) or with a FITC-labeled anti-
mouse Ig (Southern Biotechnology, Inc.) or antiThy-1.2 (Becton
Dickinson & Co., Mountain View, CA). After incubation and
washing, cells were analyzed by flow cytometry (5) .
Results
Cells Cultured with Anti-11_2R mAb and MTg Transfer In-
creasedEATandProduce Increasedanti-MTg Responses in Recip-
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ient Mice . In an initial experiment, spleen cells from
MTg/LPS-primed CBA/J mice were cultured for 72 h with
MTg in media alone or in media containing the anti-IL2R
mAbM7/20 (Table 1) . Cells cultured with M7/20 had no
detectable proliferative responses to MTg or to the T cell
mitogens ConA (Table 1) or PHA (data not shown), while
cells cultured in media alone proliferated in response to MTg,
PHA, or ConA. In most experiments, the viability of cells
cultured with MTg andM7/20was slightly lower (50-60%
ofrecovered cells) than that of cells cultured withMTgalone
(75-80%), although the percentage ofcells recovered(40-50%
of input cells) was comparable for both groups . Recipients
of 2.5 x 10' cells cultured with MTg alone all had EAT
(1-2+)19d after cell transfer and all produced anti-MTg au-
toantibody (Table 1, Exp . 1) . Surprisingly, recipients ofcells
cultured with MTg and the anti-IL-2R mAb M7/20 all de-
veloped more severe granulomatous EAT These mice also
had considerably increasedanti-MTg antibody responsescom-
pared with controls (Table 1, Exp . 1) .
Because M7/20 is an IgM antibody, the increased activity
of cells cultured with M7/20 might be explained simply by
a nonspecific effect of rat IgM or anonspecific effect ofcross-
linking IL2Rs on the cells . This is not the case since MTg-
primed spleen cells cultured with M7/20 in the absence of
MTg did not transfer EAT or produceanti-MTg in recipient
mice (Table 1, Exp. 2),and cells cultured with MTgand normal
rat IgM (Table 1, Exp . 3) or anti-Forsmann IgM (data not
shown) transferred EAT that was qualitatively and quantita-
tively similar to that inducedby cells cultured withMTg alone .
" CBA/J donor mice were immunizedwith MTg andLPS (see Materials and Methods) . Primed spleen cells were cultured 72 h with MTg (except
in line 3 of exp . 2, where no MTgwas added) ± culture supernatant (5% final concentration) containing the anti-IL-2RmAb M7/20 or 25 wg/ml
Rat IgM . Cells were washed and transferred intravenously to 600 rad irradiated CBA/J recipients .
t Thyroids were removed 19 d after cell transfer . The numbers of mice with various degrees of severity of EAT are indicated .
S Number of mice/total of group having granulomatous changes in the thyroid .
II ['H]TdRwasadded at 72 h and cells were harvested 18 h later . Data are expressed as mean A cpm ± SD of triplicate wells in the presence ofMTg
(25 Fcg/ml) or ConA (0 .5 ug/well) .
I Sera from recipient mice (19 d after cell transfer) were assessed for MTg-specific IgG autoantibodies by ELISA . Results are expressed as mean ± SEM
of OD410 of 1:100 and 1:400 dilutions of serum .
Table 1 . Induction of Severe Granulomatous EAT with Cells Cultured with MTg and Anti-IL-2R mAb
Severity of EAT# Proliferationll Anti-MTg IgG1
Granulomatous
Exp . Cells cultured with : " 0 1+ 2+ 3+ 4+ 5 + lesions MTg ConA 1/100 1/400
A cpm
1 MTg 0 2 4 0 0 0 0/6 11,124 80,575 0.274 ± 0.022 0.085 ± 0.020
MTg + M7/20 0 0 0 0 0 6 6/6 0 0 0.723 ± 0.019 0.576 ± 0.018
2 MTg 0 4 2 0 0 0 0/6 11,434 127,163 0.445 ± 0.052 0.163 ± 0.026
MTg + M7/20 0 0 0 1 3 2 6/6 102 900 0.862 ± 0.021 0.764 ± 0.033
M7/20 (No MTg) 5 0 0 0 0 0 NA ND ND 0.042 ± 0.026 0.010 ± 0.006
3 MTg 0 3 3 0 0 0 0/6 6,900 36,260 0.278 ± 0.034 0.104 ± 0.017
MTg+Rat IgM 1 5 0 0 0 0 0/6 9,100 46,540 0.366 ± 0.031 0.161 ± 0.034
MTg + M7/20 0 0 1 0 1 3 4/5 0 0 0.771 ± 0.028 0.563 ± 0.068902
Development of increased EAT effector cell activity was
dependent on the amount of M7/20 mAb. Cells cultured
with MTg and 5% M7/20-containing culture supernatant
induced the most severe (5+) granulomatous EAT. Cells cul-
tured with MTg and 1% M7/20-containing supernatant also
induced granulomatous EAT that was of 3-4+ severity com-
pared with the 1-2+ mononuclear cell infiltrates in recipients
of cells cultured with MTg and 0.2% M7/20 supernatant
or with MTg alone (data not shown) .
Spleen cells cultured with MTg and other anti-IL2R mAbs
(7134 and 3C7) also transferred more severe EAT and pro-
duced greater anti-MTg autoantibody responses than cells cul-
tured with MTg alone (Table 2). Cells cultured with MTg
and 3C7, like those cultured with MTg and M7/20, induced
granulomatous EAT in the majority of recipients (Table 2),
whereas cells cultured with MTg and 7D4 induced granuloma-
tous EAT in some (data not shown), but not all, experiments
(Table 2). The 7134 mAb, like M7/20, completely suppressed
proliferative responses to Con A and MTg, while the 3C7
mAb had relatively little effect on Con A- or MTg-specific
proliferative responses. This suggests that induction of cells
capable oftransferring granulomatous EAT and increased anti-
MTg autoantibody are not necessarily dependent on suppres-
sion of in vitro T cell proliferation. Moreover, 3C7, like
M7/20, prevents binding of IL2 to the IL2R (26), but un-
like M7/20, 3C7 is an IgG mAb. Like M7/20, 7134 is an
IgMbut binds to the IL2R at a site distal to the IL2 binding
site (26). Therefore, anti-IL2R mAbs modulate EAT effector
cell function in an antigen-specific manner, and these effects
are apparently unrelated either to isotype or site of binding
to the IL2R.
Anti-IL2R mAbs Are Required Earlyin Culture.
￿
To deter-
mine when M7/20 mediates its effects during the 72-h cul-
ture, MTg/LPS-primed spleen cells were cultured with MTg,
and M7/20 was added to separate groups of cultures at 0,
8, 24, or 48 h (Table 3). Addition ofM7/20 at 0 or 8 h resulted
in augmentation ofEAT and anti-MTg antibody by the trans-
ferred cells, although in these as well as in other experiments
See footnotes from Table 1. M7/20, 3C7, and 7134 mAbs were used at a 5% final concentration of culture supernatant.
' Results obtained with the M7/20 mAb in this experiment are shown in Table 1, exp. 2.
(data not shown), the most severe lesions and highest anti-
body responses occurred in recipients of cells cultured with
M7/20 at time 0. Addition of M7/20 at 24 or 48 h after
culture initiationresulted in little, if any, effect on the ability
of cells to induce EAT or to produce anti-MTg, although
the proliferative responses of these cells were still markedly
reduced when assessed after 72 h (data not shown). These
results indicate that M7/20 mediates its effects early in cul-
ture and also demonstrates that the effects of M7/20 are not
due to carryover of cell-bound M7/20 antibody into the re-
cipient animals.
Histopathology andKinetics ofDevelopment ofGranulomatous
EATin Recipients ofCells Cultured with M7/20. The thyroids
of recipients ofcells cultured with MTg alone appeared grossly
unremarkable and contained an inflammatory infiltrate con-
sisting primarily of lymphoid cells and a few scattered neu-
trophils (Fig. 1, A and B). This infiltrate, which was confined
to the thyroid without extension into the adjacent tissue,
replaced the thyroid follicles. While the degree of follicle
replacement varied with the severity of the infiltrate, even
in severely affected (3-4+) glands the follicularcellsremained
fairly uniform, being low to flat cuboidal cells with a scant
eosinophilic cytoplasm (Fig. 1 B).
In contrast, the thyroids ofthe majority ofmice 19 d after
receiving cells cultured with MTg and M7/20 differed both
quantitatively and qualitatively from those of mice receiving
cells cultured with MTg alone. Grossly, the thyroids with
extensive (5+) lesions were markedly enlarged, firm, and pale
white. Histologically, the thyroids were almost entirely
replaced by a diffuse inflammatory infiltrate associated with
extensive follicular destruction (Fig. 1 C); only a few residual
colloid-containing microfollicles or small follicles were still
evident (Fig. 1 D). The infiltratewas characterized by a prolifer-
ation of epithelioid histiocytes, scattered multinucleated for-
eign body-type giant cells (Fig. 1 E), and lymphocytes. Granu-
loma formation was also present, some containing central
necrosis with neutrophilic abscesses (Fig. 1, D and F). Neu-
trophils, eosinophils, and plasma cells were also evident in
Anti-interleukin 2 Receptor Antibody Effect on Autoimmune Thyroiditis
Table 2. Effect of other Anti-IL-2R Antibodies on EAT Induction
Severity of EAT Proliferation Anti-MTg IgG
Granulomatous
Exp. Cells cultured with: 0 1+ 2+ 3+ 4+ 5 + lesions MTg Con A 1/100 1/400
A cpm
1 MTg 0 0 5 1 0 0 0/6 12,420 112,600 0.193 ± 0.066 0.020 ± 0.017
MTg+M7/20 0 0 0 1 3 2 6/6 0 1,350 0.744 ± 0.031 0.270 ± 0.047
MTg+3C7 0 0 0 0 4 2 6/6 10,900 106,640 0.796 ± 0.042 0.400 ± 0.069
2' MTg 0 4 2 0 0 0 0/6 11,434 127,163 0.445 ± 0.014 0.163 ± 0.026
MTg+7D4 0 0 1 3 2 0 0/6 670 0 0.906 ± 0.045 0.735 ± 0.087the perifollicular stroma. The degree of acute inflammation
varied from a few widely scattered neutrophils to larger focal
aggregates in the stroma. Neutrophils also infiltrated the fol-
licles producing luminal microabscesses. The ratioofthe acute
to granulomatous inflammation varied, but the granuloma-
tous features were always dominant. The follicle cells were
also greatly increased in size, many being columnar, with the
cytoplasm assuming a pale to granular histiocytoid character.
Eventually, these follicle cells crowded out the luminal col-
loid, forming solid nests. As this point, it was difficult to
distinguish the follicular cells from the stromal epithelioid
histiocytes (Fig. 1, D-F). In many cases, the inflammatory
reaction extended beyond the thyroid to infiltrate the adja-
cent soft tissue and skeletal muscle (Fig. 1 G). In most cases,
the degree of cellular infiltration was much more severe in
these animals than in those receiving cells cultured with MTg
alone.
Preliminary kinetics studies were done to begin to examine
the time course ofdevelopment ofgranulomatous EAT (Table
4). Thyroid lesions in recipients of cells cultured with MTg
and M7/20 appeared earlier than in MTg control recipients,
with evidence of granulomatous changes by day 8 after cell
transfer. The earliest histologic changes consisted of a follic-
ular cell hyperplasia two to three layers of cells in thickness.
The cells became more columnar with an increase in cyto-
plasmic volume, and the nuclei also became enlarged and ir-
regular in shape. This proliferation frequently was more pro-
nounced at one aspect of the follicle, creating an eccentric




See footnotes from Table 1. M7/20 (5% final concentration of culture supernatant) was added at culture initiation (0 h) or 8, 24, or 48 h after
culture initiation.
simulated the appearanceofepithelioid histiocytes and formed
multinucleated cells difficult to distinguish in some casesfrom
the stromal histiocytes. The degreeof infiltration and granu-
loma formation increased with time to become maximal at
19 to 21 d after cell transfer. Further studies are in progress
to determine more precisely the time course of development
of these granulomatous EAT lesions.
CD4+ T Cells Are Requiredfor Induction ofEAT by Cells
Cultured with M7/20. Previous studies from this and other
laboratories have established that CD4+ T cells are the
effector cells for EAT in mice (4, 10, 21, 22). Because the
EAT lesions in mice receiving cellscultured with M7/20 are
not only more severe but also exhibit histopathologic fea-
tures not generally observed in control recipients (Fig. 1),
it was of interest to determine if CD4+ T cells were also
required for the development of severe granulomatous EAT
To address this question, recipientsofcells cultured with MTg
alone or with MTg and M7/20 were given anti-CD4 (GK1.5)
mAb either 4 or 11 d after cell transfer (Table 5). As described
previously (4), a single injection of anti-CD4 mAb almost
completely prevented the development of EAT in recipients
of control cells whether the mAb was given before disease
development (day 4) or after lesions had begun to develop
(day 11). The severity of EAT in recipients of cells cultured
with MTg and M7/20 was also markedly reduced by anti-
CD4 mAb although the majority of the treated recipients
did develop EAT The thyroids of the anti-CD4-treated
recipients of cells cultured with M7/20 contained primarily
mononuclear cell infiltrates, although four of the five 2+ le-
Table 3. M7120 Is Required Early in Culture
Severity of EAT Anti-MTg IgG
- Granulomatous
Exp. Cells cultured with: 0 1 + 2 + 3 + 4 + 5+ lesions 1/100 1/400
1 MTg 0 2 3 0 0 0 0/5 0.352 ± 0.043 0.146 ± 0.033
MTg + M7/20
(0 h) 0 0 0 0 0 5/5 0.809 ± 0.035 0.633 ± 0.063
MTg + M7/20
(8 h) 0 0 0 0 4 1 5/5 0.756 ± 0.058 0.465 t 0.022
MTg + M7/20
(24 h) 0 0 3 2 0 0 0/5 0.292 ± 0.021 0.076 ± 0.021
2 MTg 2 3 1 0 0 0 0/6 0.281 ± 0.056 0.119 ± 0.034
MTg + M7/20
(0 h) 0 0 0 0 1 5 6/6 0.974 ± 0.065 0.791 ± 0.076
MTg + M7/20
(8 h) 0 0 0 3 1 2 4/6 0.725 ± 0.069 0.677 ± 0.115
MTg + M7/20
(48 h) 0 4 2 0 0 0 0/6 0.298 ± 0.030 0.133 ± 0.030Figure 1.
￿
Hematoxylin and eosin (H & E)-stained thyroid sections from CBA/J recipients of cells cultured withMTg (A andB) or MTg + M7/20
(C-G) . (A) Conventional experimental lymphocytic thyroiditis inflammatory infiltrate (3+ to 4+)has replaced approximately halfof the thyroid paren-
chyma (H & E ; x12) . (B) Higher magnification view ofA shows a lymphocytic and mononuclear cell infiltrate between residual thyroid follicles .
The follicles are lined by a single layer ofcuboidal cells. Some follicles (arrows) are small and atrophic (H &E; x128) . (C) Experimental granulomatous
thyroiditis. Low-power view shows diffuse destruction of gland by inflammation that extends into the adjacent soft tissue and muscle (top left and
bottom left) . A few residual follicles remain . The severity of the inflammation is graded 5+ (H & E; x8). (D) Experimental granulomatous thyroiditis
(5+) .The inflammatory infiltrate has replacedtheentire gland . Numerous multinucleated giant cells are seen in lowerportion offield .Alarge granuloma
(arrow) with central abscess formation is present (H & E ; x8). (E) Granulomatous thyroiditis shows a mixture of large, multinucleated giant cells
with neutrophils, and mononuclear histiocytes.Afew atrophic follicles (arrows) remain. Note difficulty of distinguishing stromal histiocytes from follicle
cells (H & E ; x100) . (F)An area of granulomatous thyroiditis shows focal abscess surrounded by arim of epithelioid histiocytes (H & E ; x40) . (G)
Lymphohistiocytic infiltrate of granulomatous thyroiditis extends beyond the thyroid into the adjacent skeletal muscle (H & E ; x50) .
See footnotes from Table 1 .
Thyroids were removed and serum collected for ELISAs on the indicated days after cell transfer.
t Sera were obtained on the day ofEAT assessment .
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Table 4. Kinetics of Development of Granulomatous EAT in Recipients of Cells Cultured with MTg and M7120
Severity of EAT Anti-MTg IgGt
Day of EAT Granulomatous
Cells cultured with : assessment" 0 1+ 2+ 3+ 4+ 5+ lesions 1/100 1/400
MTg+M7/20 8 0 2 2 1 0 0 3/5 0.710 ± 0.039 0.337 ± 0.040
MTg 11 3 2 0 0 0 0 0/5 0.444 ± 0.088 0.109 ± 0.031
MTg+M7/20 11 0 0 0 1 4 0 5/5 0.888 ± 0.053 0.549 ± 0.086
MTg 14 2 3 0 0 0 0 0/5 0.347 ± 0.029 0.100 ± 0.048
MTg+M7/20 14 0 0 0 2 4 0 5/6 0 .884 ± 0.055 0.566 ± 0.074
MTg 21 0 0 4 1 0 0 0/5 0.420 ± 0.016 0.066 ± 0.010
MTg+M7/20 21 0 0 0 1 0 4 5/5 0.957 ± 0.083 0.776 ± 0.028Table 5.
￿
Treatment ofRecipients with Anti-CD4 mAb Suppresses Granulornatous EAT Induced by Cells Cultured with Anti-IL-2R mAb
See footnotes from Table 1.
Recipients were given 0.3 ml GK1.5 (anti-CD4) ascites 4 d (exp. 1) or 11 d (exp. 2) after cell transfer (4).
# EAT was assessed on day 19 after cell transfer except in the two groups designated with the asterisks, whereEATwas assessed 11 d after cell transfer.
$ Sera were obtained on the day of EAT assessment, i.e., day 11 for the two groups indicated by asterisks and day 19 for the other groups.
sions and the single 3+ lesion in the two experiments also
exhibited some granulomatous features. In Table 5, exp. 1,
the thyroids of untreated recipients of cells cultured with
M7/20 (line3) were essentially totally destroyedandexhibited
all of the granulornatous histopathologic features discussed
above (Fig. 1, C-G), whereas three of six anti-CD4-treated
recipients of these same cells (line 4) showed no evidence of
granulomatouschanges. Recipients ofcellscultured with MTg
and M7/20 assessed for EAT 11 d after cell transfer (Table
5, exp. 2,) already have granulomatous EAT lesions and in-
creasedanti-MTg responses relative to controls, butboth au-
toantibody responses andEAT severity furtherincrease in both
groups by day 19. A comparison of EAT severity of mice
in line 1 of Exp. 2 (Table 5) with its respective GK1.5-treated
counterpart (line4) indicates, in agreementwith ourprevious
observations (4), that GK1.5 treatment can reverse EAT in
mice. Comparisons ofline 2vs. line 6 of exp. 2 indicates that
this also appears to be true forgranulomatousEAT mediated
by cells cultured with M7/20. Injection of anti-CD4 mAb
early after cell transfer (exp. 1) also resulted in some decrease
in the anti-MTg responses, which was most evident for the
recipients of cells cultured with MTgand M7/20. However,
anti-CD4 mAb hadlittle effect on anti-MTg responses when
injected 11 d aftercell transfer (exp. 2). These results indicate
that CD4+ T cells are required to induce both the severe
granulomatous EAT lesions and the increased anti-MTg re-
sponsesin recipients ofcells cultured with MTg and M7/20.
Moreover, addition of anti-CD4 mAb to cultures with MTg
and M7/20 completely prevents activation of cells capable
of transferring EAT (data not shown).
IgG Autoantibody Responses.
￿
From the results presented
above, it is evident that recipients ofcells cultured with MTg
and M7/20 always produced more anti-MTg autoantibody
than controls. As shownin Table4, theseincreased anti-MTg
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responses were observed in recipients of cells cultured with
MTgandM7/20at all times tested, with maximalanti-MTg
IgG responses occurring on days 19-21. Although we have
never obtained severe granulomatous EAT lesions in the ab-
senceof augmented anti-MTg responses, it is notyet known
whether this increased B cell activity contributes directly to
the qualitative and/or quantitative differences in thyroid
pathology in these mice (see Discussion).
To determine if the increased autoantibody produced by
recipients of cells cultured with MTg and M7/20 was due
to preferential production of antibody ofaparticular IgG sub-
class, ELISAs were developedusing antibodies specific forIgG
subclasses (Table 6). The anti-MTg responses included anti-
body of the IgG1, IgG2A, and IgG2B subclasses and allsub-
classes were increasedrelative to controls in recipients ofcells
cultured with M7/20, 3C7, or 7D4. Little or no IgG3 anti-
body was detected in any of these sera. Thus, the increased
IgG autoantibody responses in mice receiving cells cultured
with anti-IL-2R mAbs are apparently not due to a preferen-
tial increase in antibody of aparticular IgGsubclass. In other
experiments, twofold serial dilutions of sera from recipients
of control vs. M7/20-cultured cells were tested in ELISAs
in order to more directly compare the amount of anti-MTg
produced by the two groups. The dilution at which the
OD41o reached 0.100 was used as the endpoint. Sera from
recipients ofcellscultured with MTgalonegenerallyreached
this endpoint between a 1:400 and 1:800 dilution of serum,
while sera from recipients of cells cultured with MTg and
anti-IL-2R mAbs reached this endpoint between 1:3200 and
1:12800.
Flow Cytometric Analysis ofCell-cultured Populations.
￿
To de-
termine if cells cultured in the presence of M7/20 had any
major alterations in the proportions of various cell popula-
tionsrecovered after 72 h of culture, cellscultured with MTg
Anti-interleukin 2 Receptor Antibody Effect on Autoimmune Thyroiditis













1 MTg None 0 0 1 1 4 0 2/6 0.608 ± 0.041 0.440 ± 0.044
MTg GK1.5 day 4 4 1 0 0 0 0 0/5 0.385 ± 0.066 0.232 ± 0.057
MTg+M7/20 None 0 0 0 0 0 5 5/5 0.710 ± 0.019 0.697 ± 0.019
MTg+M7/20 GK1.5 day 4 0 2 3 1 0 0 3/6 0.301 ± 0.040 0.189 ± 0.038
2 MTg` None 0 5 0 0 0 0 0/5 0.118 ± 0.056 0
MTg+M7/20" None 0 1 3 2 0 0 5/6 0.296 ± 0.033 0.035 1 0.018
MTg None 1 0 0 4 0 0 1/5 0.211 ± 0.057 0.103 ± 0.022
MTg GK1.5 day 11 3 2 0 0 0 0 0/5 0.163 ± 0.043 0.062 ± 0.013
MTg+M7/20 None 0 0 0 1 5 0 6/6 0.547 ± 0.058 0.219 ± 0.061
MTg+M7/20 GK1.5 day 11 2 2 2 0 0 0 2/7 0.379 ± 0.072 0.172 ± 0.025Sera obtained 19 d after cells transfer were tested for MTg-specific IgG autoantibodies by ELISA as described in Materials and Methods . In Exps .
1 and 2, sera were tested at a 1:400 dilution, and in Exp . 3, sera from control (MTg) recipients were at 1:100 and those from MTg+M7/20 recipients
were at 1:400 . Data are mean ± SEM of OD410 of five to six serum samples per group .
alone or MTg with M7/20 were examined by flow cytom-
etry . There was no apparent difference in the percentages of
Ig+ B cells, Thy-1+, CD8+, or CD4+ T cells, or la + or IL
2R+ cells recovered from the two groups (data not shown) .
The percentage of IL-2R + cells was quite low for both con-
trol and M7/20-cultured populations (10-15% of total cells),
and the percentage of IL-2R+ cells was even lower at 0, 24,
or 48 h of culture. Thus, the effects ofM7/20 on EAT and
anti-MTg responses cannot be attributed to a major altera-
tion in the proportions of T or B cells or to a significant
alteration in the proportion of cells expressing the IL-2R.
Discussion
At least two subsets of murine CD4+ T cell clones can
be distinguished both functionally and by the particular
cytokines they produce after activationby antigen and APC
(30-32) . One subset, Thl, produces IL-2, IFN-y, and lym-
photoxin, while the Th2 subset produces IL-4, I1r5, and IL-6
(30-32) . Th2 are very effective helper cells for B cells, espe-
cially for the production of IgE and IgG1 antibody (31-34) .
While Thl cells can provide help to B cells, particularly for
IgG2A responses (31-34), they are generally less effective
helpers than are Th2 cells (31-33, 35, 36) . There is some
evidence that CD4+ T cells corresponding to Thl and Th2
subsets also exist among noncloned CD4+ T cells in vivo
and that differential activation of CD4+ T cell subsets after
immunization may lead to qualitatively distinct immune re-
sponses (31, 32, 37-40) . In addition, Thl-like cells are reported
to be the major proliferating T cells in antigen-primed lymph
nodes (32) .
The present study demonstrates thatwhen immune spleen
cells containing effector T cells for EAT were activated in
vitro with MTg in the presence of anti-IL2R mAb, these
cells induced severe granulomatous EAT in recipient mice.
909
￿
Braley-Mullen et al .
Although MTg was absolutely required to activate cells to
transfer granulomatous EAT in conjunction with anti-IL2R
mAb (Table 1, Exp. 2), cell division in vitro apparently was
not required since both MTg-specific and mitogen-induced
proliferative responses were undetectable in the presence of
the M7/20 and 7D4 mAbs (Tables 1 and 2) . Since CD4+
T cells are required for development of both classical lym-
phocytic EAT and severe granulomatousEAT (Table 5), acti-
vation of different CD4+ T cell subsets in the presence vs.
the absence of anti-IL2R mAb could explain our results . It
is tempting to speculate that CD4+ Th2-like cells induce se-
vere granulomatous EAT accompanied by high anti-MTg au-
toantibody responses, while Thl-like cells may either induce
less severe lymphocytic EAT or suppress activation of Th2-
likeEAT effector cells. Since bothThl and Th2 cells express
IL2R and respond to IL-2 (30, 32, 41, 42), anti-11,2R mAb
must preferentially bind to Thl or inhibit the activation or
function ofThl but not ofTh2 cells. Since IL4 is the auto-
crine growth factor for Th2 cells (41, 42), blocking of IL2-
induced growth by anti-11,2R mAb might enable Th2-like
cells to be activated by locally produced IL4 . Moreover, IL4-
producing T cells can be selectively expanded by culturing
antigen-primed T cells with IL4 and IL-1 in the presence of
anti-IL-2R mAb (43) . There is also evidence that in vivo in-
jection of anti-11,21k mAb suppresses the function of Thl-
like cells while having little or no effect on Th2-like cells
that provide help toB cells (44) . It should also be noted that
IL4-producing Th2 clones can induceEAT in mice (45) . One
of these clones, B7, induced severe EAT characterized by the
striking presence ofneutrophils ; this clone was very effective
in providing help to B cells (22) . Moreover, we have found
that MTg-sensitized spleen cells cultured with MTg in the
presence of mAbs specific for IL2 and IFN-y also transfer
severe granulomatous EAT and increased anti-MTg autoanti-
body responses (Mullen, H . B., G. Sharp, J . Bickel, andM.
Table 6 . Subclass Distribution of MTg-speck IgG Autoantibodies
MTg-specific IgG*
Exp . Cells cultured with : IgG1 IgG2A IgG2B
1 MTg 0.209 ± 0.051 0.094 ± 0.051 0.003 ± 0.003
MTg + M7/20 0.468 ± 0.052 0.560 ± 0.072 0.155 ± 0.045
MTg + 3C7 0.581 ± 0.053 0.636 ± 0.084 0.285 ± 0.094
2 MTg 0.239 ± 0.034 0.319 ± 0.047 0.032 ± 0.016
MTg + M7/20 0.342 ± 0.028 0.831 ± 0.011 0.392 ± 0.028
MTg + 7D4 0.389 ± 0.038 0.773 ± 0.036 0.469 ± 0.046
3 MTg 0.349 ± 0.031 0.416 ± 0.023 0.091 ± 0.031
MTg +M7/20 0.558 ± 0.025 0.664 ± 0.025 0.491 ± 0.039Kyriakos, manuscriptin preparation). Thus, all these observa-
tions are consistent with the hypothesis that Th2-like CD4+
T cells induce severe granulomatous EAT and Th1-like cells
or their products may downregulate the function of these
cells. We are currently attemptingto derive MTg-specific Th1
and Th2 clones in order to directly test this hypothesis.
The fact that severe granulomatous EAT lesions were always
accompanied by increased anti-MTg autoantibody responses
raises the possibility that MTg-specific B cells and/or anti-
MTg autoantibody may contribute to the pathophysiology
of these lesions. While CD4+ T cells alone can induce se-
vere EAT resembling in some respects the lesions produced
by cells cultured with anti-IIr2R mAb (22; S.J. Stull, un-
published observations), further studies (currently in prog-
ress) are required to directly address this issue. It is of interest
that the increased anti-MTg responses in recipients of cells
cultured with anti-IIr2R mAb are comprised of at least three
IgG subclasses, IgG1, IgG2A, and IgG2B, with no apparent
preferential increase of a particular IgG subclass (Table 6).
This is perhaps unexpected if anti-IIr2R mAb inhibits acti-
vation of Th1 cells, since IFN-y produced by Th1-like cells
is presumably required for IgG2A production (31-34). How-
ever, since B cells were initially primed in donor mice where
activation of Th1-like cells was not prevented, commitment
to IgG2A production may have occurred before exposure of
the cells to anti-11,2R mAb.
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